TCRP1 contributes to cisplatin resistance by preventing Pol β degradation in lung cancer cells
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
TCRP1 contributes to cisplatin resistance by preventing Pol β degradation in lung cancer cells
Authors
Keywords
TCRP1, DDP resistance, Pol β, DNA repair
Journal
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume 398, Issue 1-2, Pages 175-183
Publisher
Springer Nature
Online
2014-09-26
DOI
10.1007/s11010-014-2217-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancer
- (2014) S. Novello et al. ANNALS OF ONCOLOGY
- Absence of superoxide dismutase activity causes nuclear DNA fragmentation during the aging process
- (2014) Khandaker Ashfaqul Muid et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Systems biology of cisplatin resistance: past, present and future
- (2014) L Galluzzi et al. Cell Death & Disease
- Observing a DNA Polymerase Choose Right from Wrong
- (2013) Bret D. Freudenthal et al. CELL
- Global estimates of cancer prevalence for 27 sites in the adult population in 2008
- (2012) Freddie Bray et al. INTERNATIONAL JOURNAL OF CANCER
- Association between polymorphisms of XRCC1 and ADPRT genes and ovarian cancer survival with platinum-based chemotherapy in Chinese population
- (2012) Kai Li et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Repair of cisplatin-induced DNA interstrand crosslinks by a replication-independent pathway involving transcription-coupled repair and translesion synthesis
- (2012) Milica Enoiu et al. NUCLEIC ACIDS RESEARCH
- Microarray-Assisted Pathway Analysis Identifies MT1X & NFκB as Mediators of TCRP1-Associated Resistance to Cisplatin in Oral Squamous Cell Carcinoma
- (2012) Bo Peng et al. PLoS One
- Purification and biochemical characterization of a novel protein—tongue cancer chemotherapy resistance-associated protein1 (TCRP1)
- (2012) Bo Peng et al. PROTEIN EXPRESSION AND PURIFICATION
- Genome Instability Caused by a Germline Mutation in the Human DNA Repair Gene POLB
- (2012) Robert W. Sobol PLoS Genetics
- Cloning and functional characterization of TCRP1, a novel gene mediating resistance to cisplatin in an oral squamous cell carcinoma cell line
- (2011) Yixue Gu et al. FEBS LETTERS
- TCRP1 promotes radioresistance of oral squamous cell carcinoma cells via Akt signal pathway
- (2011) Yixue Gu et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- USP47 Is a Deubiquitylating Enzyme that Regulates Base Excision Repair by Controlling Steady-State Levels of DNA Polymerase β
- (2011) Jason L. Parsons et al. MOLECULAR CELL
- A novel regulatory circuit in base excision repair involving AP endonuclease 1, Creb1 and DNA polymerase β
- (2010) De-Sheng Pei et al. NUCLEIC ACIDS RESEARCH
- Circadian control of XPA and excision repair of cisplatin-DNA damage by cryptochrome and HERC2 ubiquitin ligase
- (2010) T.-H. Kang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Ubiquitin ligase ARF-BP1/Mule modulates base excision repair
- (2009) Jason L Parsons et al. EMBO JOURNAL
- A platinum agent resistance gene,POLB, is a prognostic indicator in colorectal cancer
- (2009) Masaaki Iwatsuki et al. JOURNAL OF SURGICAL ONCOLOGY
- Platinum Resistance: The Role of DNA Repair Pathways
- (2008) L. P. Martin et al. CLINICAL CANCER RESEARCH
- Kinetics of H2AX phosphorylation after exposure to cisplatin
- (2008) Peggy L. Olive et al. CYTOMETRY PART B-CLINICAL CYTOMETRY
- CHIP-Mediated Degradation and DNA Damage-Dependent Stabilization Regulate Base Excision Repair Proteins
- (2008) Jason L. Parsons et al. MOLECULAR CELL
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now